Abstract
Background: Diabetes mellitus (DM) is a widespread chronic metabolic disease which has high mortality due to its complications. In addition to traditional medication, stem cell transplantation therapeutics has become a brand-new and prospective remedy for DM. With strong self-renewal and multi-potential ability, mesenchymal stem cells (MSCs) are considered as ideal cell sources of cell therapy for DM and many other diseases. However, not only do endogenous MSCs fail to replace the impaired islet cells, but also transplanted MSCs fail to cure many patients complicated with DM. Besides, quite a few DM patients suffer from high risk of fracture and low efficiency of bone regeneration, which are often associated with the osteoblastic differentiation of MSCs. Recently, a number of researches have investigated that the changes in micro-environment by DM can affect biological characteristics of MSCs through many factors.
Summary: In this review, we summarize the developments in the influence of DM on proliferation and osteoblastic differentiation of MSCs, and moreover, osteoporosis, obesity and metabolism syndrome, as they are closely related to DM.Keywords: Diabetes mellitus, mesenchymal stem cells, proliferation, osteoblastic differentiation, osteoporosis, obesity, metabolism syndrome
Current Stem Cell Research & Therapy
Title:The Influence of Diabetes Mellitus on Proliferation and Osteoblastic Differentiation of MSCs
Volume: 12 Issue: 5
Author(s): Jun Tan, Lihua Zhou, Yang Zhou, Peng Xue, Guangsheng Wu, Guangying Dong, Hang Guo and Qintao Wang*
Affiliation:
- Department of Periodontology, School of Stomatology, The Fourth Military Medical University, 145 West Changle Road, Xi`an, Shaanxi 710032, P. R. China,China
Keywords: Diabetes mellitus, mesenchymal stem cells, proliferation, osteoblastic differentiation, osteoporosis, obesity, metabolism syndrome
Abstract: Background: Diabetes mellitus (DM) is a widespread chronic metabolic disease which has high mortality due to its complications. In addition to traditional medication, stem cell transplantation therapeutics has become a brand-new and prospective remedy for DM. With strong self-renewal and multi-potential ability, mesenchymal stem cells (MSCs) are considered as ideal cell sources of cell therapy for DM and many other diseases. However, not only do endogenous MSCs fail to replace the impaired islet cells, but also transplanted MSCs fail to cure many patients complicated with DM. Besides, quite a few DM patients suffer from high risk of fracture and low efficiency of bone regeneration, which are often associated with the osteoblastic differentiation of MSCs. Recently, a number of researches have investigated that the changes in micro-environment by DM can affect biological characteristics of MSCs through many factors.
Summary: In this review, we summarize the developments in the influence of DM on proliferation and osteoblastic differentiation of MSCs, and moreover, osteoporosis, obesity and metabolism syndrome, as they are closely related to DM.Export Options
About this article
Cite this article as:
Tan Jun, Zhou Lihua, Zhou Yang, Xue Peng, Wu Guangsheng, Dong Guangying, Guo Hang and Wang Qintao*, The Influence of Diabetes Mellitus on Proliferation and Osteoblastic Differentiation of MSCs, Current Stem Cell Research & Therapy 2017; 12 (5) . https://dx.doi.org/10.2174/1574888X10666151001114527
DOI https://dx.doi.org/10.2174/1574888X10666151001114527 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus
Current Clinical Pharmacology Dual Role of S100A8 and S100A9 in Inflammation-Associated Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications
Current Drug Targets Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Use of Antiplatelet Drugs in the Treatment of Acute Coronary Syndromes
Cardiovascular & Hematological Disorders-Drug Targets The New Perspectives on Genetic Studies of Type 2 Diabetes and Thyroid Diseases
Current Genomics The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients
Current Medicinal Chemistry A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Current Neuropharmacology Drug Therapy for Behavioral and Psychological Symptoms of Dementia
Current Neuropharmacology Dysregulation of Glycogen Synthase Kinase-3 in Skeletal Muscle and the Etiology of Insulin Resistance and Type 2 Diabetes
Current Diabetes Reviews Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
Current Drug Targets Quality of Life and Self-care Behavior Among People Living with Diabetes- A Study from Coastal South India
Current Diabetes Reviews Increased Alzheimer’s Disease Neuropathology is Associated with Type 2 Diabetes and ApoE ε4 Carrier Status
Current Alzheimer Research Endothelial Extracellular Vesicles Produced by Senescent Cells: Pathophysiological Role in the Cardiovascular Disease Associated with all Types of Diabetes Mellitus
Current Vascular Pharmacology Perinatal and Neonatal Outcomes of Lithium-Treated and Untreated Bipolar Women During Pregnancy: A Review of Present Literature
Current Psychopharmacology Recent Medicinal Chemistry Studies for Multitarget Agents-Part II
Current Drug Targets Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Detection of Glucose in Human Serum Based on Silicon Dot Probe
Current Analytical Chemistry Fighting Diabetes Mellitus: Pharmacological and Non-pharmacological Approaches
Current Pharmaceutical Design Proliferative Retinopathies: Animal Models and Therapeutic Opportunities
Current Neurovascular Research